Evaluating Risk Factors for Developing Hypoglycemia During Treatment of Hyperkalemia With Intravenous Regular Insulin.
Autor: | Beard, Meghan M., McKenzie, Jeffrey J., Potter, Terry G., Varney Gill, Kimberly |
---|---|
Předmět: |
RISK assessment
ACADEMIC medical centers T-test (Statistics) PATIENT safety HYPERKALEMIA SEX distribution INSULIN RETROSPECTIVE studies DESCRIPTIVE statistics CHI-squared test INTRAVENOUS therapy BLOOD sugar ELECTRONIC health records MEDICAL records ACQUISITION of data DRUG efficacy CONFIDENCE intervals HYPOGLYCEMIA REGRESSION analysis DISEASE risk factors |
Zdroj: | Journal of Pharmacy Practice; Oct2024, Vol. 37 Issue 5, p1091-1098, 8p |
Abstrakt: | Background: The conventional dose of 10 units of intravenous (IV) regular insulin to treat hyperkalemia has been associated with hypoglycemia. There have been retrospective studies evaluating weight-based dose vs conventional dose of IV regular insulin but the comparative efficacy and safety is not well established. Objective : Evaluate the difference in weight-based dosing of IV regular insulin between patients who experienced hypoglycemia vs. patients who did not experience hypoglycemia after the administration of IV regular insulin. Methods: This was a retrospective, electronic chart review at a single academic medical center which included patients ≥18 years of age with an emergency department or inpatient encounter who were administered IV regular insulin within 6 hours of a pre-treatment potassium of ≥5 mmol/L. Results: There was no significant difference in the weight-based insulin dose between patients who experienced a hypoglycemic event and patients who did not experience a hypoglycemic event (.14 vs.22 units/kg; P =.44). The potassium-lowering effect was similar between the two groups (1.02 vs.96 mmol/L; P =.56). A regression analysis revealed that female sex, low baseline blood glucose (glucose <140 mg/dL), and those who received a repeat dose of IV regular insulin were independent risk factors for development of hypoglycemia. Conclusion: This study found no difference in hypoglycemic events and potassium lowering based on IV weight-based regular insulin dosing, however other risk factors may predict hypoglycemia. [ABSTRACT FROM AUTHOR] |
Databáze: | Complementary Index |
Externí odkaz: |